Prognostic factors and clinical trials.
The identification of prognostic factors is an important area of cancer research. This article contains an introduction to the uses of prognostic factors, statistical methods for their identification, and a summary of the literature concerning the evolution of serum beta 2 microglobulin as a prognostic factor in multiple myeloma.
Dixon
D O
DO
Department of Biomathematics MD Anderson Cancer Center.
D014408:Biomarkers, Tumor / Q000032:analysis*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000378:metabolism* / Q000628:therapy; D009369:Neoplasms / Q000032:analysis* / Q000628:therapy; D011237:Predictive Value of Tests; D011379:Prognosis; D001613:beta 2-Microglobulin / Q000032:analysis*
D014408:Biomarkers, Tumor; D001613:beta 2-Microglobulin